In the latest trading session,, 0.75 million Iterum Therapeutics Plc (NASDAQ:ITRM) shares changed hands as the company’s beta touched 2.82. With the company’s most recent per share price at $1.12 changing hands around $0.08 or 7.69% at last look, the market valuation stands at $44.80M. ITRM’s current price is a discount, trading about -169.64% off its 52-week high of $3.02. The share price had its 52-week low at $0.81, which suggests the last value was 27.68% up since then.
Analysts gave the Iterum Therapeutics Plc (ITRM) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended ITRM as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. Iterum Therapeutics Plc’s EPS for the current quarter is expected to be 0.
Iterum Therapeutics Plc (NASDAQ:ITRM) trade information
Instantly ITRM is in green as seen in intraday trades today. With action 16.69%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -36.72%, with the 5-day performance at 16.69% in the green. However, in the 30-day time frame, Iterum Therapeutics Plc (NASDAQ:ITRM) is 10.89% up.
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 29.27%. The 2025 estimates are for Iterum Therapeutics Plc earnings to increase by 57.87%, but the outlook for the next 5-year period is at 55.20% per year.
ITRM Dividends
Iterum Therapeutics Plc is expected to release its next quarterly earnings report in July.
ANCORA ADVISORS, LLC holds the second largest percentage of outstanding shares.
With 12.37 shares estimated at $13359.0 under it, the former controlled 0.03% of total outstanding shares.
